Dieckol

ID: dieckol

Aliases: Ecklonia cava dieckol

Type: compound

Route/form: route not curated

Status: research_or_supplement

Evidence level: preclinical

Best data tier: direct preclinical; adjacent human controlled/review

Support scope: human, non-human/mechanistic

Source types: human_rct, in_vitro, preclinical

Linked sources: 3

Broad outcomes: Cardiovascular / lipids / blood pressure

Reading note: These are curation notes anchored to linked sources, not a clinical recommendation or protocol.

Targets / mechanism

Optimization domains

Research basis

Limits, risks, and missing evidence

Risk flags

Linked papers, labels, and reviews

  1. Dieckol attenuates endothelial dysfunction via Th17/Treg balance in spontaneously hypertensive rats
    preclinical / pubmed_dieckol_endothelial_shr_2021
    Ecklonia cava/dieckol, peNOS/eNOS, nitrate/nitrite, NADPH oxidase, Treg/Th17 source.
  2. Protective effects of dieckol isolated from Ecklonia cava against high glucose-induced oxidative stress in HUVECs
    in_vitro / sciencedirect_dieckol_huvec_2009
    Direct dieckol endothelial-cell oxidative-stress source; mechanistic only.
  3. Effect of seaweed (Ecklonia cava extract) on blood glucose and insulin level on prediabetic patients
    human_rct / pubmed_ecklonia_prediabetes_rct_2022
    Human Ecklonia cava extract RCT; adjacent extract-level metabolic data, not isolated dieckol cardiovascular proof.